Using these leads, an attempt to develop rapid point-of-care technology to detect TB would be a nice initiative in the direction of giving better serological tests with approved validation. In practice, it requires the political will at the level of DCGI, high level support from agencies such as RNTCP and the ICMR. Without such measures the "vision 2020" of "Global TB Elimination" will eliminate itself and TB microbes will keep evading the human habitat, adding to the suffering of humans.

References:

1. Steingart KR, Henry M, Laal S, and others . Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PloS Med 2007; 4;e202.
2. World Health Organization. Diagnostics Evaluation Series No.2. Laboratory-based evaluation of 19 commercially available rapid diagnsotic tests for tuberculosis. Geneva: World Health, Organization; 2008.
3. Harinath B.C. Immunodiagnostics for tuberculosis-Problems and Progress. Indian J Tuberculosis 2010; 57:I23-I27.
4. Haldar S, BoseM, Chakrabarti P, and others . Improved laboratory diagnosis of tuberculosis- The Indian experience. Tuberculosis. 2011;91:414-426.